Families for Depression Awareness will address the Food and Drug Administration (FDA) as they convene for the Psychopharmacological Drugs Advisory Committee (PDAC) meeting, December 13. The FDA panel will address suicide risk data from adult antidepressant trials. [click link for full article]
More...